{
  "id": "5c6549e1e842deac67000022",
  "type": "yesno",
  "question": "Can CPX-351 be used for the treatment of tuberculosis?",
  "ideal_answer": "No, CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin which has recently been FDA approved for treatment of acute myeloid leukemia (AML).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29167924"
  ],
  "snippets": [
    {
      "text": "CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin which has recently been FDA approved for treatment of acute myeloid leukemia (AML).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29167924",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}